超快通道与传统拔管在非急诊心脏手术中的临床影响:CARDU-FAST随机临床试验
CARDU-FAST为单中心随机临床试验,纳入612例择期重大心脏手术成人患者,比较手术室内即刻拔管(超快通道,UFT)与ICU早期拔管(快通道,FT)。主要复合终点(全因死亡、呼吸并发症、AKIN III期急性肾损伤)发生率UFT组6.5%、FT组10.1%,差异无统计学意义(P=0.105);UFT未增加不良事件,并改善多项次要结局。
要点
- UFT未显著降低主要复合终点,但未增加不良事件风险。
- UFT组延长插管(>24 h)、无创通气及因出血再手术比例均低于FT组。
- UFT与更短的ICU及住院时间相关,适用于经仔细筛选的心脏手术患者。
核心结论
- 在意向性治疗分析中,UFT未显著降低主要复合终点,但与多项次要结局改善相关,且未增加不良事件风险。
- 研究结果提示,在经仔细筛选的心脏手术患者中,UFT可能具有潜在获益。
研究设计与样本
- 单中心随机临床试验,2023年2月至2024年11月在一家三级心血管中心开展,围术期与麻醉管理标准化。
- 共纳入612例接受重大非急诊心脏手术的成人患者,随机分为UFT组(n=306)与FT组(n=306)。
- UFT组在手术室内拔管,FT组在ICU内早期拔管。
主要发现
- 主要复合终点(全因死亡、呼吸并发症、AKIN III期急性肾损伤)发生率UFT组6.5%、FT组10.1%,差异无统计学意义(P=0.105)。
- 延长插管(>24 h)发生率UFT组2.0%、FT组7.5%(P=0.001)。
- 需无创通气比例UFT组5.6%、FT组11.1%(P=0.013)。
- 因出血再手术比例UFT组2.6%、FT组6.9%(P=0.013)。
- 与FT相比,UFT与更短的ICU住院时间和总住院时间相关,并降低术后低心排血量综合征发生率。
关键数值与推荐
- 主要终点为全因死亡、呼吸并发症(插管>24 h、再插管、肺炎)与AKIN III期急性肾损伤的复合终点。
- UFT组主要复合终点6.5%,FT组10.1%,P=0.105。
- 延长插管UFT组2.0% vs FT组7.5%,P=0.001;无创通气5.6% vs 11.1%,P=0.013;因出血再手术2.6% vs 6.9%,P=0.013。
临床怎么用
- 对经仔细筛选的重大非急诊心脏手术患者,可考虑手术室内即刻拔管的超快通道策略。
- 实施UFT需依托标准化的围术期与麻醉管理流程,并关注呼吸并发症与出血再手术等次要结局。
- 主要复合终点未达统计学差异,UFT的应用应结合患者个体情况权衡。
局限性
- 为单中心研究,结果外推需谨慎。
- 原文摘要未报告盲法、样本量计算及主要终点效能等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immediate extubation in the operating theatre (Ultra Fast-Track, UFT), compared with early extubation in the intensive care unit (ICU) (Fast-Track, FT), has been proposed as a strategy to improve postoperative recovery after cardiac surgery. However, its effect on major clinical outcomes remains unclear. OBJECTIVE: To compare the risk of a composite outcome including perioperative all-cause mortality, respiratory complications, and acute kidney injury between UFT and FT in patients undergoing major nonemergency cardiac surgery. DESIGN: Single-centre, randomised clinical trial conducted between February 2023 and November 2024. SETTING: A tertiary cardiovascular centre with standardised perioperative and anaesthetic management. PARTICIPANTS: A total of 612 adult patients undergoing major cardiac surgery were randomised to UFT (n = 306) or FT (n = 306). INTERVENTION: Patients in the UFT group were extubated in the operating theatre, whereas patients in the FT group underwent early extubation in the ICU. MAIN OUTCOMES AND MEASURES: The primary endpoint was a composite outcome of all-cause mortality, respiratory complications (prolonged intubation >24 h, reintubation, pneumonia), and stage III acute kidney injury (AKIN III). RESULTS: The primary composite endpoint occurred in 6.5% of patients in the UFT group and 10.1% in the FT group, with no statistically significant difference (P = 0.105). Compared with FT, UFT was associated with shorter ICU and hospital length of stay, lower rates of prolonged intubation (2.0 versus 7.5%; P = 0.001), reduced need for noninvasive ventilation (5.6 versus 11.1%; P = 0.013), fewer reoperations for bleeding (2.6 versus 6.9%; P = 0.013) and a lower incidence of postoperative low cardiac output syndrome. CONCLUSIONS: Although UFT did not significantly reduce the primary composite outcome in the intention-to-treat (ITT) analysis, it was not associated with an increased risk of adverse events but was associated with improvements in several secondary outcomes. These findings suggest potential benefits of UFT in carefully selected cardiac surgery patients. TRIAL REGISTRATION: Evaluation of clinical impact of UFT versus conventional extubation in patients undergoing cardiac surgery. CARDU-FAST clinical trial. ClinicalTrials.gov Identifier: NCT05706857.
引用
- Cruces LM, Alcázar MC, Sial RLB, et al. Evaluation of clinical impact of ultra fast-track versus conventional extubation in patients undergoing nonemergency cardiac surgery: 'CARDU-FAST': A randomised clinical trial. Eur J Anaesthesiol. 2026. PMID: 42046539. doi:10.1097/EJA.0000000000002400
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。